Botulinum neurotoxin A (BoNT/A) cleaves SNAP25 at the motor nerve terminals and inhibits stimulus evoked acetylcholine release. This causes skeletal muscle paralysis. However, younger neonatal mice (<P7; <7-days old) are resistant to the neuroparalytic effects of BoNT/A. That is, in vivo injection of BoNT/A at the innervations of Extensor digitorum longus muscle in the hindlimbs inhibited the toe spread reflex within 24 hours following BoNT/A injection in adult mouse and in older (>P7) mice. However, neonatal mice younger than 7 days-age remained unaffected by BoNT/A injection. Also, BoNT/A inhibited stimulus evoked acetylcholine release and stimulus-evoked twitch tension of diaphragm nerve muscle preparations (NMPs) of adult mouse and >P7 neonates but not that of <P7. Moreover, NMPs of <P7 showed decreased uptake of fluorescent BoNT/A compared to >P7. However, cholesterol depletion using methyl-b-cyclodextrin (MbCD) sensitized <P7 neonates to BoNT/A and facilitated BoNT/A uptake into NMPs obtained from <P7 neonates. Further, MbCD (10 mM; 30 min pretreatment) increased the interaction between synaptic vesicle protein 2 and BoNT/A. Also, cholesterol depletion increased the miniature endplate current in adult NMPs. Interestingly, cholesterol replenishment, in vitro, delayed the onset of inhibitory effect of BoNT/A. Collectively, our data suggest that cholesterol rich lipid microdomains are involved in BoNT/A uptake mechanisms during development. Our data demonstrate that cholesterol depletion sensitized neonatal mice (<P7) to BoNT/A while replenishing cholesterol delayed the onset of inhibitory actin of BoNT/A. This suggests that membrane cholesterol modulates neurotoxin sensitivity at the neuromuscular junction (NMJ).
At the motor nerve terminal (MNT) SNARE complex proteins regulate the docking and fusion of synaptic vesicle. The 7 serotypes of BoNTs (/A through/G) are produced by Clostridium botulinum. Botulinum neurotoxin A (BoNT/A) is the principal serotype and is a potential biothreat agent (Marks, 2004) . BoNT/ A holotoxin consists of a 100 kDa heavy chain (Hc, receptor binding domain) and a 50 kDa light chain (Lc) linked by a single disulfide bond. BoNT/A Hc binding to its receptors on the neural membrane sets the stage for endocytosis into the MNT. Separation of Lc and Hc takes place after translocation of Lc in the reducing cytosol (Pirazzini et al., 2015) . The Hc translocates the Lc into the cytosol where it cleaves SNAP-25 and attenuates ACh release resulting in flaccid neuroparalysis of the innervated muscles in adult mice.
However, in early 1980s younger rats were reported to recover from botulinum-induced paralysis much more quickly than adults. In a study with neonatal mice, it was observed that intragastric administration of Clostridium botulinum spores to mice <7-days old showed resistance to botulinum intoxication (Sugiyama and Mills, 1978) . In this research study, we report that neonatal mice, younger than 7 days of age (<P7) showed resistance to BoNT/A and that cholesterol depletion by MbCD sensitized these neonates to the neurotoxin. We analyzed this systematically by investigating the effects of BoNT/A in wild type and MbCD treated diaphragm nerve muscle preparations (NMPs) obtained from <P7, >P7 (older than 7 days of age) and adult mice.
Our data provide evidence for the role of cholesterol in the regulation of BoNT/A uptake mechanism. This knowledge is very useful for ensuring careful clinical use of BoNT/A when administered along with medications that perturb cellular cholesterol levels.
MATERIALS AND METHODS

Surgical Procedure and Injections
Adult and neonatal (age P3-P10) C57BL/6 wild type mice were used for the study. All protocols were conducted as per protocols approved by Institutional Animal Care and Use Committee. Aseptic techniques were used for surgical procedures in mice for in vivo experiments. Mice were anesthetized with intraperitoneal injection of a mixture of ketamine (80 mg/kg) and xylazine (10 mg/kg). A small incision in the skin at the knee region was made in the leg where the peroneal nerve enters into the extensor digitorum longus (EDL) muscle. Three microliters of BoNT/A (1.066 pg/ml) in HEPES Ringer solution (HRS) containing mM 135 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 5 HEPES, and 5.5 glucose was injected into the space surrounding the innervation site of the EDL with a 26-gauge needle attached to a Hamilton syringe. The skin incision was closed with 4-0 nylon suture. HRS (3 ml) injected-contralateral EDL muscles in the left limb served as sham-treated controls. First evaluation of toe spread reflex (TSR) was done at 12 h. after the injections. TSR could not be continued for more than 24 h. since the paralyzed neonates (<p7) did not survive for more than 24 h. following cholesterol depletion with MbCD.
Assessment of TSR
Typically, when the mouse is lifted by its tail, peroneal muscles spread the second, the third, and the fourth toes, and this constitutes peroneal nerve function index (Gutmann et al., 1942) . It serves as a sign of functional recovery. The effect of BoNT/A on the TSR in neonate and adult mice was evaluated according to the procedure described in an earlier report (Thyagarajan et al., 2010) . The evaluation of TSR is subjective and therefore, the investigators conducting the test were unaware (blinded) of the treatment groups. The TSR measurement was scored from 1 to 5 depending on the number of toes that the mouse could extend from the midline of the foot when the animal was lifted by the tail. The mice were observed every day for a period of 7 days after injection of the toxin.
Recording Twitch Tension
Phrenic nerve diaphragm muscles preparations from adult or neonatal (>P7 and <P7) mice were removed after the mice were fully anesthetized with isoflurane followed by cervical dislocation. Left and right hemidiaphragms with the innervating phrenic nerves were dissected and mounted in a glass chamber (Radnoti Glass Technology, Inc., Monrovia, CA, USA) filled with oxygenated (95% O 2 -5% CO 2 ) normal Ringer's solution (pH 7.4, 37 C) containing 135 mM NaCl, 5 Mm KCl, 1 mM MgCl2, 2 mM CaCl2, 1 mM Na2HPO4, 15 mM NaHCO3, 5.5 mM glucose. The phrenic nerve was drawn into a suction electrode for indirect activation of muscle twitches. The central tendon of the hemidiaphragm muscle was tied to a Grass Force transducer connected to a Digidata 1440A (Molecular Devices, Sunnyvale, California). The data acquisition and analysis of mechanical responses of the isolated diaphragm to nerve stimulation were performed with PCLAMP 10 software (Molecular Devices Inc., USA). The muscle preparations were adjusted to optimal length for force generation and equilibrated for 15 min before stimulation at 1 Hz for data acquisition.
Electrophysiology
Measurement of miniature end plate potentials or currents and stimulus-evoked endplate potentials or currents recorded from diaphragm NMPs. Diaphragm NMPs with phrenic nerve were removed from adult mice or neonatal mice anesthetized with isoflurane followed by cervical dislocation. Isolated NMP were pinned to a Sylgard-lined Plexiglas chamber, and bathed in HRS (22 C) containing (mM) NaCl 135; KCl 5; CaCl2; MgCl2 1; dextrose 5.5 and HEPES 5. In control preparations 0.75 mM m-conotoxin GIIIB (Alamone Labs, Israel) was added to the bath to inhibit muscle contractions in response to phrenic nerve stimulation. In experiments performed to study the effects of BoNT/A (10 pM) after in vitro exposure (bath application), the procedure was as described before (Thyagarajan et al., 2009 Nonidet 40 and complete protease inhibitor cocktail (GE Healthcare, Little Chalfont, Buckinghamshire, UK). Homogenates of Neuro 2a cells were prepared in the same manner. After centrifuging the homogenate at 14 000 rpm for 10 min in the cold, the crude lysate (40 lg) was resolved via SDS-polyacrylamide gel electrophoresis after boiling in 1Â aemmli buffer. Immunoblotting was performed with anti-rabbit SV2 polyclonal antibody (detects all 3 SV2-SV2A, SV2B and SV2C; Developmental Study Hybridoma Bank, Iowa City, USA). For immunoprecipitation, the homogenized samples were precleared with Protein A Sepharose 4 beads and incubated with non-immune serum or specific antibody (SV2; AB2315387, DSHB, Iowa City, USA) overnight at 4 C. Protein A beads was then added to samples for 2 h at 4 C, pelleted by centrifugation and washed 3 times with lysis buffer (50 mM HEPES, pH 8.0/1 mM EDTA/150 mM NaCl, 1% Triton and protease inhibitors). Proteins were eluted with 1% SDS buffer, resolved by 7.5% SDS/ PAGE, and analyzed by immunoblotting with BoNT/A Hc antibody.
Cholesterol Depletion by MbCD and Cholesterol Supplementation
Solutions of 10 mM MbCD or aCD (control) was prepared by dissolving it in sterile filtered HRS. For cholesterol supplementation, we used MbCD saturated with cholesterol (Ch-MbCD).
Concentration of 3 ll of 10mM MbCD, Ch-MbCD, or aCD was injected into right EDL of neonates. For in vitro experiments, 10 mM MbCD was used to deplete cholesterol 30 min. prior to 10 pM BoNT/A addition. Typically, for electrophysiological recordings to measure mEPP and EPP were made for the MbCD or aCD treated diaphragm NMPs.
Data Analyses
Data for all figures were expressed as mean 6 SD for n ¼ 8 mice, 
RESULTS
BoNT/A Inhibits Stimulus-Evoked EPP and Twitch Tension in Adult Mice and P7 Neonates but Not in P3 Neonates
Experiments were performed in diaphragms isolated from adult mice and P7 and P3 neonates. Sample records of EPPs (1 Hz nerve-elicited) and the mean values for their amplitude are shown in Figure 1 . Control recordings were obtained in the presence of m-conotoxin to block muscle twitches (Figs. 1A-C).
Control value for the EPPs was around 12 mv for adult, P7 and P3 MNT. Interestingly for adult and P7 diaphragms exposure to BoNT/A (10 pM) for 90 min produced block of neuromuscular transmission (NMT) as seen by lack of EPP response to even increased stimulus strength. On the contrary, NMP of P3 mouse was unaffected by the neurotoxin as shown by a robust EPP of about 11 mV which was followed by a small mEPP ( Figure 1C ). The mean EPP amplitudes in NMP of muscles from adult, P7 and P3 diaphragm NMPs for before BoNT/A application were 12.22 6 3.76, 11.94 6 3.54, and 12.06 6 3.12 mV, respectively, and 90 min after BoNT/A exposure were 0.10 6 0.002, 0.08 6 0.001, and 11.48 6 3.06 mV, respectively. These results confirmed the finding that the MNT in neonate mice <P7 is resistant to BoNT/A-induced block of NMT. Next, we analyzed the effect of BoNT/A on stimulus-evoked twitch tension in diaphragm NMPs isolated from adult, >P7 and <P7 mice. As illustrated in Figure 2 , the stimulus evoked twitch tension values for adult and >P7 neonates were 100% and 1.02 6 0.001% and 100% and 1.14 6 0.002%, respectively, while that for <P7 neonates were 100% and 91.521% at 0 min and at 90 min. following BoNT/A treatment.
Diaphragm NMPs of Neonates Do Not Endocytose BoNT/A
In order to evaluate whether NMPs of neonates younger than 7 days endocytose BoNT/A, we performed stimulus evoked fluorescence BoNT/A uptake experiments in diaphragm of adult, P8 and P4 mice.
Experiments performed with BoNT/A labeled with Alexa Fluor 647 demonstrated that MNTs from diaphragms of mice (P < 7) failed to demonstrate toxin uptake into cholinergic nerves. The right-hand column of Supplementary Figure 1 represents confocal images of motor end-plates in adult, P8 and P4 NMPs labeled with Alexa Fluor 647-BoNT/A and the left-hand column shows the corresponding postsynaptic labeling by Alexa Fluor 488 a-BnTX.
Depletion of Cholesterol by MbCD Sensitizes Neonate Mouse MNT to
BoNT/A Membrane cholesterol is an important regulator of synaptic vesicle recycling (Puchkov and Haucke, 2013) . Membrane cholesterol depletion by MbCD increases spontaneous vesicle fusion rates at the neuromuscular junction while decreased evoked release (Petrov et al., 2014; Rodrigues et al., 2013; Tarakanova et al., 2011) . SV2 is a receptor for BoNT/A (Dong et al., 2006; Mahrhold et al., 2006; Weisemann et al., 2016) that is present in vesicles that fuse and release ACh at the MNT. Therefore, we evaluated whether depletion of cholesterol sensitizes neonatal mice to BoNT/A. To achieve this, we pretreated isolated MNPs BoNT/A inhibits stimulus evoked twitch tension of diaphragm NMPs for the adult and P7 (or older) but not P3 (or younger than P7) neonates. A, Time courses of stimulus evoked twitch tension in adult and neonates (>P7 and <P7 old). B. Bar graphs represent the summary of mean 6 SD of stimulus evoked twitch tension, at 0 and 90 min at 37 C after BoNT/A (10 pM) application in the bath, in these mice (n ¼ 6 for each conditions). C. Sample traces of twitch tension for the above conditions. from < P7 neonates with MbCD (10 mM for 30 min. at RT) and then measured stimulus evoked endplate potentials (EPPs). As described in Figures 3A and B , BoNT/A alone did not inhibit EPPs in P3 MNPs while pretreatment\with MbCD (10 mM for 30 min) conferred sensitivity to BoNT/A in P3 NMPs. The mean EPP amplitude 6 STDEV for control (aCD; 10 mM 30 min), MbCD, BoNT/A (10 pM) and BoNT/A þ MbCD (30 min pretreatment with 10 mM MbCD followed by 90 min. of BoNT/A treatment) were measured to be 8.76 6 0.77, 8.94 6 0.89, 8.44 6 0.26, and 1.89 6 0.012 mV, respectively. Further, the mEPP frequency for adult and P3 NMPs before and after MbCD treatment were determined to be 1.82 6 0.31 and 2.88 6 0.56 mV (adult) and 0.54 6 0.14 and 0.88 6 0.20 mV (P3), respectively.
Neuroparalysis After a Local Injection of BoNT/A in P3 Mice After MbCD A single local injection of BoNT/A into EDL muscle of right hind limb of adult mouse produced paralysis which was evident as early as 24 h. post injection. The paralysis of right foot was seen by the lack of reflex spreading of toes when the mouse was lifted by its tail. The left foot from HRS injected EDL showed normal TSR (Figure 4 ). Similar injections of the neurotoxin in P3-P7 mice failed to demonstrate any paralysis of the hind limbs. Normally at this age the mice do not have righting reflex and the ability to move using their fore or hind limbs. This precluded measurement of TSR. None of the neonates (P2-P6) that received BoNT/A showed any paralysis up to 2 months of observation period. The resistance to block of NMT was best demonstrated by injecting MbCD (3 ll of 10 mM) 30 min prior to BoNT/A injection. The percentages of neuroparalysis following the injection of BoNT/A in the adult and P8 mice and that following the injection BoNT/A postaCD, MbCD, or cholesterol saturated MbCD in P3 mice are shown in Figure 4 .
Next, we analyzed the ability of BoNT/A to cause inhibition of stimulus-evoked twitch tension in P3 mice diaphragm NMPs following cholesterol depletion with MbCD ( Figure 5 ). The twitch tension percentage at 0, 30, 60 and 90 min. post BoNT/A treatment in aCD or MbCD pretreated (10 mM; 30 min) NMPs are given in Table 1 .
MbCD-Induced Cholesterol Depletion Enhances Uptake of BoNT/A by Nerve Terminal Membrane
Since cholesterol depletion sensitized the P3 neonates to BoNT/ A, we evaluated whether MbCD treatment stimulated BoNT/A uptake into P3 NMPs. As shown in Supplementary Figure 2 , pretreatment of the NMP with aCD failed to enhance the uptake of florescent labeled BoNT/A while MbCD pretreatment facilitated BoNT/A uptake into P3 (Supplementary Figure 2) and P4 NMPs (Supplementary Figure 5B) at 22 C. We also measured the effect of MbCD treatment on stimulus-evoked twitch tension at 22 C (RT) and 37 C (Supplementary Figures 3A and B) . We calculated the percent of twitch tension in adult diaphragm NMPs at time 0 and at time 120 min following pretreatment with 10 mM MbCD (Supplementary Figure 3C) . MbCD pretreatment per se did not significantly decrease stimulus-evoked twitch tension of NMPs.
Since cholesterol depletion by MbCD < P7 sensitized neonates to BoNT/A, we evaluated whether MbCD treatment sped up the onset of inhibition of stimulus evoked endplate current (EPCs) in adult NMPs. We performed these experiments in EDS NMPs, which were exposed to either buffer (control; aCD) or MbCD (10 mM for 30 min) before exposure to BoNT/A. The EPC amplitudes (nA) at the beginning of the experiment and at 40 min and 90 min after BoNT/A exposure are shown in Figure 6 . Table 2 shows the EPC amplitudes for these conditions. Next, we evaluated the effect of MbCD pretreatment on BoNT/Ainduced inhibition of twitch tension in P7 diaphragm NMPs. For this, we pretreated NMPs isolated from P7 (7-day-old mice) with 10 mM MbCD for 30 min and then measured the stimulus evoked twitch tension in the presence of either 10, 3, or 1 pM BoNT/A. We also measured the twitch tension in the presence BoNT/A (10 pM) but without MbCD preincubation, which served as control. As shown in Figure 7 , MbCD pretreatment significantly enhanced the inhibitory effect of all 3 concentrations of BoNT/A. Under control (only BoNT/A and no MbCD) conditions, BoNT/A inhibited twitch tensions completely in about 136.45 6 18.44 min. while MbCD treatment shortened the time to inhibition of twitch tension to about 68.16 6 14.34 min. Although, no significantly difference was observed among the 3 concentrations of BoNT/A, preincubation with MbCD significantly shortened the time to 50% inhibition of twitch tension by 10 pM of BoNT/A compared with 1 or 3 pM BoNT/A.
To determine whether MbCD treatment may directly alter the membrane permeability of BoNT/A, we determined the effect of BoNT/A Lc (1 M for 90 min) following MbCD treatment. We expected that if MbCD can directly enhance the internalization of LC/A, then LC/A should suppress the EPP in adult and neonatal (P4) diaphragm NMPs. As shown in Supplementary Figure 5A , LC/A did not cause any paralysis either in the adult or in P4 NMPs.
Previous research suggests that the SNAP-25 isoform determines the differential sensitivity to BoNT/A (Puffer et al., 2001) . So, one possibility is that MbCD treatment may enhance the more susceptible form of SNAP-25. We, therefore, analyzed the mRNA levels of SNAP-25 a and b in the developing and adult NMJ but these results were inconclusive due to high cycle time values (data not shown). We therefore, analyzed the expression of SNAP-25 and its cleavage product in the adult and developing NMJ (P4) Figure 9A ) with these treatments clearly points out that BoNT/A produced complete block of NMT by 95 6 4.43 min while NMPs treated with MbCD and BoNT/A were blocked within about 38.4 6 2.66 and 51.2 6 4.85 min, respectively. The beneficial effect of cholesterol supplementation was evident by longer time (133 6 5.18 min, Figure 9A ) required to produce total paralysis of NMP. The data is best shown by calculating time to 50% block with each treatment ( Figure 9B ).
DISCUSSION
At the adult mammalian NMJ, BoNT/A suppresses ACh release (Baskaran and Thyagarajan, 2014) . Although previous research suggests the lack of effect of BoNT/A in neonatal mice following oral administration, the reason for the ability of rat neonates to recover quickly from BoNT/A paralysis or the effect of BoNT/A on immature and developing NMJ have not been studied in detail previously. The enhanced recovery was attributed to return of polyneural innervations in the younger rats (Brown et al., 1981) . Also, mice that are <7-days old were resistant to botulism due to negligible systemic absorption of the toxin in these neonates. These data suggest that differential mechanisms regulate toxin's sensitivity and recovery in neonates compared with adults. However, the role of cholesterol rich LMDs in this process has been analyzed earlier.
This research specifically evaluated the effect of injection of BoNT/A in the hindlimbs of neonates (either <P7 or more than P7) and adult mice. We also evaluated the effect of BoNT/A on the diaphragm NMPs isolated from these groups of mice. We chose to work with diaphragm NMPs due to the ease of access of the tissue as well as due to the nature of diaphragm, being an important tissue for respiratory functions. We present a novel finding that neonatal mice, <7-days old, are resistant to the neuroparalytic effect of BoNT/A, while cholesterol depletion by MbCD sensitized these neonates to BoNT/A.
CDs are routinely used for extracting membrane cholesterol in research. We used 2 kinds of CDs, to perform experiments. aCD, which does not bind cholesterol in the same way as MbCD (Ohtani et al., 1989; Rodal et al., 1999) was used as a control. Since aCD decreased cholera-toxin binding to gangliosides (Ermolinsky et al., 2013) , we used it to evaluate its effect on BoNT/A sensitivity at the neonatal and adult NMJ. Both CDs were used at a concentration of 10 mM on neonatal or adult NMJ. Our data suggest that MbCD but not aCD sensitized neonatal mice to BoNT/A. This suggests membrane cholesterol is a critical regulator of BoNT/A sensitivity. Also, it important to note that upon neuroparalysis caused by BoNT/A in MbCD preinjected <P7 neonates, cannibalism was observed with the mother. So, we could not conduct long-term effects of BoNT/Ainduced neuroparalysis and recovery aspects in younger neonates.
Cholesterol is an important regulator of synaptic vesicle recycling and neuromuscular functions. Cholesterol depletion suppresses evoked release but enhances spontaneous release at the crayfish NMJ (Zamir and Charlton, 2006) . Cholesterol rich LMDs control membrane fluidity and help in the clustering of acetylcholine receptors at the post synaptic nerve terminals (Pato et al., 2008; Stetzkowski-Marden et al., 2006) . On the other hand, cholesterol depletion by MbCD enhances BoNT/A activity (Petro et al., 2006) and increases spontaneous neurotransmission and enhances spontaneous vesicle endocytosis (Wasser et al., 2007) . Consistently, our data suggest a critical role of cholesterol in regulating endocytic mechanism of BoNT/A in the developing NMJ. Previous published work suggest that cholesterol depletion by MbCD suppressed stimulus evoked release (Zamir and Charlton, 2006) . However, preincubation of NMPs 10 mM MbCD for 30 min followed by washing the NMPs with HEPES Ringer buffer for 30 min did not reduce the EPP or EPC amplitudes however sensitized the NMPs to BoNT/A. Also, performing cholesterol depletion by MbCD at 37 C only slightly decreased (up to 5%) the twitch tension compared with aCD-treated control (Supplementary Figs. 3B and C) . These data suggest that perturbation of cholesterol levels at the NMJ facilitated BoNT/A uptake and sensitivity. However, it does not rule out an effect of MbCD that is independent of its ability to chelate cholesterol (Ormerod et al., 2012) . Nonetheless, the sensitivity of BoNT/A caused by MbCD was not observed when cholesterol saturated MbCD or aCD was used for in vivo BoNT/A injection in the hindlimbs of neonates (Figure 4 ). Our data also suggest that the sensitization of neonatal NMPs is associated with a corresponding increase in the frequency of mEPP in both adult and neonatal NMPs ( Figure 3C ). This observation raised an important question-whether increase in mEPP would facilitate BoNT/A uptake? BoNT/A uptake in NMP is increased upon stimulation (Rummel et al., 2009) . It has been shown previously that treatment of NMPs with hyperkalemic buffer (40 or 75 mM KCl extracellularly) significantly facilitated BoNT/A uptake in the adult NMPs as well as Neuro 2a cells (Baskaran et al., 2013; Kitamura et al., 2009; Thyagarajan et al., 2009 Thyagarajan et al., , 2010 . High potassium containing buffers enhanced vesicle fusion density at active zones (Grohovaz et al., 1989) and increased miniature endplate potentials to facilitate the uptake of the neurotoxin. Consistently, MbCD treatment also facilitated BoNT/A uptake (Supplementary Figure 2) and increased mEPPs in neonatal and adult NMPs ( Figure 3C ). Therefore, it is reasonable to speculate that MbCD would facilitate BoNT/A uptake by increasing spontaneous vesicle fusion, which would expose more synaptic vesicle glycoprotein (SV2) to the membrane to facilitate BoNT/A uptake/. However, the effect of MbCD on gangliosides (another receptor for BoNT/A) still remains to be elucidated at the NMJ. Therefore, an alternate possibility is that MbCD-mediated cholesterol depletion alters the clustering of gangliosides, which would facilitate BoNT/A uptake. Further studies are required to address this mechanism. A third possibility is that the expression of endocytic machinery that governs BoNT/A uptake could not be fully developed in younger neonates. Perhaps, cholesterol depletion induced reorganization of lipid rafts may facilitate BoNT/A endocytosis. Therefore, further studies are required to understand the mechanisms that underlie the resistance to BoNT/A in the developing NMJ.
At the MNTs, synaptic vesicle glycoproteins (SV2), along with gangliosides functions as the receptor for BoNT/A. Experiments performed to evaluate the effect of MbCD on SV2 expression in Neuro 2a cells suggest that MbCD treatment (10 mM for 30 in) significantly increased SV2 expression in these cells. Also, MbCD treatment enhanced the interaction between SV2 and BoNT/A (Figs. 8B and C) in Neuro 2a cells suggesting the facilitation of SV2 availability for toxin binding (Figure 8 ). Consistent to this observation, a previous report suggests that cholesterol depletion or lipid raft inhibition facilitated the binding of BoNT/A in Neuro 2a cells (Ayyar and Atassi, 2016) . Moreover, disruption of lipid rafts enhanced the activity of BoNT/A in cultured Neuro 2a cells possibly by increasing the spontaneous vesicle endocytosis due to cholesterol depletion (Wasser et al., 2007) .
If cholesterol depletion sensitizes neonatal mice to BoNT/A and enhanced the effect of BoNT/A in adult NMPs, supplementation of cholesterol via water soluble cholesterol should prevent the effect of MbCD. Consistent to this notion, cholesterol saturated MbCD failed to cause neuroparalysis in younger neonates (P3; Figure 4 ) and delayed the onset of inhibitory action of BoNT/A on stimulus evoked twitch tension in the adult NMPs (Figure 9) . Collectively, our data suggest that cholesterol is an important determinant of BoNT/A sensitivity at the developing NMJ and perturbation to NMJ cholesterol enhances the uptake and action of the toxin in the neonatal and adult NMJ. This research predominately focused on the effect of toxin following cholesterol depletion. However, how cholesterol depletion modulates the interaction between SNARE complex proteins in developing and adult synapses still remains to be determined. Our data support a model (Supplementary Figure 4) in which cholesterol depletion enhances the effect of BoNT/A by increasing spontaneous vesicle fusion. Nonetheless, how the enhancement of spontaneous vesicle fusion facilitates BoNT/A uptake needs to be answered in the future studies.
The discovery of the lack of sensitivity of BoNT/A in the younger neonates (<7 days of age) and its sensitization by cholesterol depletion suggest that cholesterol is important for the regulation exo-endocytic mechanisms at the NMJ during development.
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